IHS Chemical Week

People & Business :: M&A

Amgen and Astellas form biopharmaceuticals joint venture in Japan

9:28 AM MDT | May 29, 2013 | Natasha Alperowicz

Amgen (Thousand Oaks, CA), the world's largest independent biotechnology company; and Astellas Pharma (Tokyo), a leading pharmaceutical company, have entered into a strategic alliance to provide new medicines to help address serious unmet medical needs of Japanese patients, the companies announced today.   The alliance leverages the complementary capabilities of both companies through an innovative business model that combines Amgen's pipeline candidates with Astellas's knowledge of Japanese patient and physician needs, long-term commercial and regulatory...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa